Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHISX vs. FHLC: which is better?

Bottom line

SHISX vs FHLC: the short answer

SHISX (Blackrock Health Sciences Opportunities Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.

But FHLC is far broader, holding 337 positions to 155 for SHISX, so beyond the top names it adds exposure SHISX doesn't have.

FHLC is cheaper at 0.084% vs 1.16% — a difference of $108 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +5.5% for SHISX (reporting dates differ).

Updated Nov 19, 2026

SHISX vs FHLC side by side

SHISXFHLC
TypeMutual fundETF
Fund familyBlackRockFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.16%0.084%
Annual cost per $10k$116$8.4
10-yr cost on $10k (prospectus)$1,409$108
Max front load—None
12b-1 fee0.25%0%
1-yr return+15.9%+2.6%
5-yr return (annualized)+5.5%+7.2%
10-yr return (annualized)+9.5%+8.8%
Best quarter+17.5%+16.4%
Worst quarter−11.5%−13.1%
Net assets (fund)$5.9B$3.3B
Number of holdings155337
Portfolio turnover49%3%
Returns as ofDec 31, 2025Nov 30, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHISXFHLCDifference
2024+3.8%+2.6%+1.2%
2023+3.5%+2.5%+1.0%
2022−6.0%−5.5%−0.5%
2021+11.7%+20.4%−8.6%
2020+19.4%+18.1%+1.3%
2019+25.3%+21.9%+3.3%
2018+8.0%+5.5%+2.4%
2017+24.8%+23.3%+1.5%
2016−6.1%−3.3%−2.7%
2015+11.0%+7.0%+4.0%

Source: Fund prospectus bar charts

Holdings overlap

17 of SHISX's top 25 holdings also appear in FHLC's top 25.

Shared top holdings
HoldingSHISXFHLC
Eli Lilly & Company12.29%13.35%
Johnson & Johnson8.77%8.93%
Unitedhealth Group Inc6.10%5.44%
Merck & Company Inc4.94%4.66%
Gilead Sciences Inc4.19%2.34%
Abbvie Inc3.94%6.42%
Amgen Inc3.37%3.00%
Thermo Fisher Scientific Inc3.02%3.09%
Vertex Pharmaceuticals Inc2.74%1.76%
Pfizer Inc2.61%2.06%
Danaher Corp2.00%1.80%
Abbott Laboratories1.97%2.66%
Intuitive Surgical Inc1.95%1.82%
Boston Scientific Corp1.59%1.00%
Elevance Health Inc1.56%1.19%

Source: SEC Form N-PORT

SHISX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

FAQ

What is the difference between SHISX and FHLC?
SHISX (Blackrock Health Sciences Opportunities Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds. But FHLC is far broader, holding 337 positions to 155 for SHISX, so beyond the top names it adds exposure SHISX doesn't have.
Which is cheaper, SHISX or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both SHISX and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.